Induction of cell-mediated immunity during early stages of infection with intracellular protozoa

Brazilian Journal of Medical and Biological Research

Volumn 31, Issue 1, 1998, Pages 89-104

  Gazzinelli, R T ^a,b   Talvani, A ^a,b   Camargo, M M ^a,b   Santiago, H C ^a   Oliveira, M A P ^a   Vieira, L Q ^a   Martins, G A ^c   Aliberti, J C S ^c   Silva, J S ^c  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines; Leishmania; Macrophages; Nitric oxide; Toxoplasma gondii; Trypanosoma cruzi

Indexed keywords

PROTOZOA; TOXOPLASMA GONDII; TRYPANOSOMA; TRYPANOSOMA CRUZI; VERTEBRATA;

CYTOKINE;

ANIMAL; CELLULAR IMMUNITY; IMMUNOLOGY; LEISHMANIA; PHYSIOLOGY; PROTOZOAL INFECTION; REVIEW; TOXOPLASMA; TRYPANOSOMA CRUZI;

ANIMALS; CYTOKINES; IMMUNITY, CELLULAR; LEISHMANIA; PROTOZOAN INFECTIONS; TOXOPLASMA; TRYPANOSOMA CRUZI;

EID: 0031609199     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1998000100012     Document Type: Article

References (105)

1. Frenkel JK (1988). Pathophysiology of toxoplasmosis. Parasitology Today, 4: 273-278.
2. Brener Z (1973). Biology of Trypanosoma cruzi. Annual Review of Microbiology, 27: 347-382.
3. Gazzinelli RT, Denkers EY & Sher A (1993). Host resistance to Toxoplasma gondii: a model for studying the selective induction of cell-mediated immunity by intracellular parasites. Infectious Agents and Disease, 2: 139-149.
4. Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, Anderson D & Reed SG (1992). Interleukin 10 and interferon-γ regulation of experimental Trypanosoma cruzi infection. Journal of Experimental Medicine, 175: 169-174.
5. Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, Caspar P, Trinchieri G & Sher A (1994). Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. Journal of Immunology, 153: 2533-2543.
6. Aliberti JCS, Cardoso MAG, Martins GA, Gazzinelli RT, Vieira LQ & Silva JS (1996). IL-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infection and Immunity, 64: 1961-1967.
7. Vespa GNR, Cunha FQ & Silva JS (1994). Nitric oxide is involved in the control of Trypanosoma cruzi-induced parasitemia and directly kills parasite in vitro. Infection and Immunity, 62: 5177-5182.
8. Scharton-Kersten TM, Wynn TA, Denkers EY, Bala S, Grunvald E, Hieny S, Gazzinelli RT & Sher A (1996). In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. Journal of Immunology, 157: 4045-4054.
9. Tarleton RL, Koller BH, Latour A & Postan M (1992). Susceptibility of β2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature, 356: 338-340.
10. Minoprio P, Eisen H, Joskowicz M, Pereira P & Coutinho A (1987). Suppression of polyclonal antibody production in murine Trypanosoma cruzi-infected mice by treatment with anti-L3T4 antibodies. Journal of Immunology, 139: 545-550.
11. Krettli AU & Brener Z (1976). Protective effects of specific antibodies in Trypanosoma cruzi infections. Journal of Immunology, 116: 755-760.
12. . Luft BJ, Brooks RG, Conley FK, McCabe RE & Remington JS (1984). Toxoplasmic encephalitis in patients with acquired immune response deficiency syndrome. Journal of the American Medical Association, 252: 913-917.
13. Navia BA, Petito CK, Gold JWM, Cho ES, Jordan BD & Price RW (1986). Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathologic findings in 27 patients. Annals of Neurology, 19: 224-238.
14. Rocha A, Meneses ACO, Silva AM, Ferreira MS, Nishioka SA, Burgarelli NKM, Almeida E, Turcato Jr G, Metze K & Lopes ER (1994). Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. American Journal of Tropical Medicine and Hygiene, 50: 261-268.
15. Bogdan C, Gessner A, Solbach W & Rolinghoff M (1996). Invasion, control and persistence of Leishmania parasites. Current Opinion in Immunology, 8: 517-525.
16. Descoteaux A, Matlashewski G & Turco SJ (1992). Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan. Journal of Immunology, 149: 3008-3015.
17. Moore KJ, Labrecque S & Matlashewski G (1993). Alteration of Leishmania donovani infection levels by selective impairment of macrophage signal transduction. Journal of Immunology, 150: 4457-4465.
18. Reiner SL, Zheng SC, Wang ZE, Stowring L & Locksley RM (1994). Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4(+) T cells during initiation of infection. Journal of Experimental Medicine, 179: 447-456.
19. Carrera L, Gazzinelli RT, Badolato R, Hieny S, Müller W, Kühn R & Sacks DL (1996). Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. Journal of Experimental Medicine, 183: 515-526.
20. Proudfoot L, O'Donnell CA & Liew FY (1995). Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages. European Journal of Immunology, 25: 745-750.
21. Belosevic M, Finbloom DS, Van der Meide PH, Slayter MV & Nacy CA (1989). Administration of monoclonal anti-IFN-γ antibodies in vivo abrogates natural resistance of H/HeN mice to infection with Leishmania major. Journal of Immunology, 143: 266-274.
22. Sypek JP, Chung CL, Mayor SEH, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF & Schaub RG (1993). Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. Journal of Experimental Medicine, 177: 1797-1802.
23. Camargo MM, Almeida IC, Pereira MES, Ferguson MAJ, Travassos LR & Gazzinelli RT (1997). GPI-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of pro-inflammatory cytokines by macrophages. Journal of Immunology, 158: 5890-5901.
24. Gazzinelli RT, Hieny S, Wynn T, Wolf S & Sher A (1993). Interleukin 12 is required for the T-lymphocyte independent induction of interferon-γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proceedings of the National Academy of Sciences, USA, 90: 6115-6119.
25. Grunvald E, Chiaramonte M, Hieny S, Wysocka M, Trinchieri G, Vogel SN, Gazzinelli RT & Sher A (1995). Biochemical characterization and protein kinase C dependency of monokine inducing activities in Toxoplasma gondii. Infection and Immunity, 64: 2010-2018.
26. Gazzinelli RT, Amichay D, Scharton-Kersten T, Grunvald E, Farber JM & Sher A (1996). Role of macrophage-derived cytokines in the induction and regulation of cell mediated immunity to Toxoplasma gondii. Current Topics in Microbiology and Immunology, 219: 127-140.
27. Gazzinelli RT, Eltoum I, Wynn TA & Sher A (1993). Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. Journal of Immunology, 151: 3672-3681.
28. Gazzinelli RT, Camargo MM, Almeida IC, Morita YS, Giraldo M, Acosta-Serrano A, Hieny S, Englund PT, Ferguson MAJ, Travassos LR & Sher A (1997). Identification and characterization of protozoan products that trigger the synthesis of IL-12 by inflammatory macrophages. Chemical Immunology, 68: 136-152.
29. Camargo MM, Andrade AC, Almeida IC, Travassos LR & Gazzinelli RT (1997). Glycoconjugates isolated from Trypanosoma uzi but not from Leismania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-γ-primed macrophages. Journal of Immonology (In press).
30. Gazzinelli RT, Morita YS, Hieny S, Englund PT & Sher A (1997). Identification and isolation of adjuvant molecules from Toxoplasma gondii tachyzoites. Memórias do Institute Oswaldo Cruz (In press).
31. Vieira LQ, Hondowicz BD, Afonso LCC, Wysocka M, Trinchieri G & Scott P (1994). Infection with Leishmania major induces interleukin-12 production in vivo. Immunology Letters, 40: 157-161.
32. Marth T & Kelsall BL (1997). Regulation of interleukin-12 by complement receptor 3 signalling. Journal of Experimental Medicine (in press).
33. Karp CL, Wysocka M, Wahl LM, Ahearn JM, Cuomo PJ, Sherry B, Trinchieri G & Griffin DE (1996). Mechanism of suppression of cell-mediated immunity by measles virus. Science, 273: 228-231.
34. Mosser DM & Edelson PJ (1987). The third component of complement (C3) is responsible for the intracellular survival of Leishmania major. Nature, 327: 329-331.
35. Oliveira MAP, Santiago HC, Lisboa CR, Ceravolo IP, Gazzinelli RT & Vieira LQ (1996). Comparative studies on the ability of Leishmania sp., Toxoplasma gondii and Trypanosoma cruzi in initiating IL-12 and IFN-γ synthesis both in vitro and in vivo. XXI Reunião Anual da Sociedade Brasileira de Imunologia, 1: 139 (Abstract).
36. Bancroft GJ, Sheehan KC, Schreiber RD & Unanue ER (1989). Tumor necrosis factor is involved in the T-cell-independent pathway of macrophage activation in scid mice. Journal of Immunology, 143: 127-130.
37. Bancroft GJ, Schreiber RD & Unanue ER (1991). Natural immunity: a T-cell-independent pathway of macrophage activation, defined in scid mouse. Immunological Reviews, 124: 5-24.
38. Sher A, Oswald IP, Hieny S & Gazzinelli RT (1993). Toxoplasma gondii induces a T-independent IFN-γ response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-α. Journal of Immunology, 150: 3982-3989.
39. Cardillo F, Voltarelli JC, Reed SG & Silva JS (1996). Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin-10: the role of NK cells. Infection and Immunity, 64: 128-134.
40. Hunter CA, Chizzonite R & Remington JS (1995). IL-1β is required for IL-12 to induce production of IFN-γ by NK cells. Journal of Immunology, 155: 4347-4354.
41. . Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani N, Grabstein K & Caligiuri M (1995). Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. Journal of Clinical Investigation, 96: 2578-2582.
42. Hunter CA, Bermudez L, Beernink H, Waegell W & Remington JS (1995). Transforming growth factor-β inhibits interleukin-12-induced production of interferon-γ by natural killer cells: a role for transforming growth factor-β in the regulation of T cell-mediated resistance to Toxoplasma gondii. European Journal of Immunology, 25: 994-1000.
43. Kaye PM & Bancroft GJ (1992). Leishmania donovani infection in scid mice: Lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural-killer cell-derived gamma interferon production in vitro. Infection and Immunity, 60: 4335-4342.
44. Varkila K, Chatelain R, Leal LM & Coffman RL (1993). Reconstitution of C.B.-17 SCID mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection. European Journal of Immunology, 23: 1531-1538.
45. Scott P (1991). IFN-γ modulates the early development of Th1 and Th2 responses in murine model of cutaneous leishmaniasis. Journal of Immunology, 147: 3149-3155.
46. Reiner SL & Locksley RM (1995). The regulation of immunity to Leishmania major. Annual Review of Immunology, 13: 151-177.
47. Heinzel FP, Sadick MD, Holaday BJ & Locksley RM (1989). Reciprocal expression of interferon-gamma or IL-4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. Journal of Experimental Medicine, 169: 59-72.
48. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS & Locksley RM (1990). Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon γ-independent mechanism. Journal of Experimental Medicine, 171: 115-127.
49. Scott P, Natovitz P, Coffman RL, Pearce E & Sher A (1988). Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. Journal of Experimental Medicine, 168: 1675-1684.
50. . Gajewski TF & Fitch FW (1988). Anti-proliferative effect of IFN-γ in immunoregulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. Journal of Immunology, 140: 4245-4251.
51. + T lymphocytes, and NK cells. Journal of Immunology, 149: 3495-3502.
52. Trinchieri G (1995). Interleukin-12: a pro-inflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptative immunity. Annual Review of Immunology, 13: 252-276.
53. Hsieh CS, Macatonia SE, Tripp CS, Wolf S, O'Garra A & Murphy KM (1993). Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science, 260: 547-549.
54. Seder RA, Gazzinelli RT, Sher A & Paul WE (1993). IL-12 acts directly on CD4+ T cells to enhance priming for IFN-γ production and diminishes IL-4 inhibition of such priming. Proceedings of the National Academy of Sciences, USA, 90: 10188-10192.
55. Afonso LCC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G & Scott P (1994). The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science, 263: 235-237.
56. Swain SL, Weinberg M, English M & Huston G (1990). IL-4 directs the development of Th2-like helper effectors. Journal of Immunology, 145: 3796-3806.
57. Le Gros G, Ben-Sasson SZ, Seder R, Finkelman FD & Paul WE (1990). Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. Journal of Experimental Medicine, 172: 921-929.
58. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE & Gately MK (1993). Recombinant interleukin 12 cures mice infected with Leishmania major. Journal of Experimental Medicine, 177: 1505-1509.
59. Schartor TM & Scott P (1993). Natural killer cells are a source of IFN-γ that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. Journal of Experimental Medicine, 178: 567-577.
60. Scharton-Kersten T, Afonso LCC, Wysocka M, Trinchieri G & Scott P (1995). IL-12 is required for natural killer cell activation and subsequent T helper 1 cell delopment in experimental leishmaniasis. Journal of Immunology, 154: 5320-5330.
61. Murray HW & Hariprashad J (1995). Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. Journal of Experimental Medicine, 181: 387-391.
62. Heinzel FP, Rerko RM, Ahmed F & Pearlman E (1995). Endogenous interleukin-12 (IL-12) is required for control of Th2 CD4+ T cell responses capable of exacerbating leishmaniasis in normally resistant C57BL/6 mice. Journal of Immunology, 155: 730-739.
63. Hsieh CS, Macatonia SE, O'Garra A & Murphy KM (1995). T cell genetic background determines default T helper phenotype development in vitro. Journal of Experimental Medicine, 181: 713-721.
64. + T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. Journal of Immunology, 146: 286-292.
65. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. Journal of Immunology, 149: 175-180.
66. Krishnan L, Guilbert LJ, Russell AS, Wegmann TG, Mosmann T & Belosevic M (1996). Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigenspecific IFN-γ responses and increased production of helper 2 cytokines. Journal of Immunology, 156: 644-652.
67. Miller MD & Krangel MS (1992). Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Critical Reviews in Immunology, 12: 17-46.
68. Kelvin DJ, Michiel DF, Johnston JA, Lloyd AR, Sprenger H, Oppenheim JJ & Wang JM (1993). Chemokines and serpentines: the molecular biology of chemokine receptors. Journal of Leukocyte Biology, 54: 604-612.
69. Baggiolini M & Dahinden CA (1994). CC chemokines in allergic inflammation. Immunology Today, 15: 127-133.
70. Murphy PM (1994). The molecular biology of leukocyte chemoattractant receptors. Annual Review of Immunology, 12: 593-633.
71. Aliberti JCS, Ferreira LRP, Talvani A, Farber J, Silva JS & Gazzinelli RT (1996). The intracellular protozoa Trypanosoma uzi and Toxoplasma gondii induce the expression of multiple chemokines by inflammatory murine macrophages. XXI Reunião Anual da Sociedade Brasileira de Imunologia, 1: 93 (Abstract).
72. Amichay D, Gazzinelli RT, Karupiah G, Moench T, Sher A & Farber J (1996). The genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-γ with patterns of tissue expression that suggest nonredundant roles in vivo. Journal of Immunology, 157: 4511-4520.
73. Talvani A, Murta S, Soares S, Michailowski V, Aliberti JS, Farber J, Amichay D, Romanha AJ & Gazzinelli RT (1996). Chemokine expression during experimental Chagas' disease. XXI Reunião Anual da Sociedade Brasileira de Imunologia, 1: 106 (Abstract).
74. Badolato R, Sacks D, Savoia D & Musso T (1996). Leishmania major: infection of human monocytes induces expression of IL-8 and MCAF. Experimental Parasitology, 82: 21-26.
75. Racoosin EL & Beverley SM (1997). Leishmania major: promastigotes induce expression of a subset of chemokine genes in murine macrophages. Experimental Parasitology, 85: 283-295.
76. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M & O'Garra A (1991). IL-10 inhibits cytokine production by activated macrophages. Journal of Immunology, 147: 3815-3822.
77. Gazzinelli RT, Oswald IP, James S & Sher A (1992). IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ activated macrophages. Journal of Immunology, 148: 1792-1796.
78. Oswald IP, Gazzinelli RT, Sher A & James SL (1992). IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. Journal of Immunology, 148: 3578-3582.
79. Reed SG, Brownell CE, Russo DM, Silva JS, Grabstein KH & Morrissey PJ (1994). IL-10 mediates susceptibility to Trypanosoma cruzi infection. Journal of Immunology, 153: 3135-3140.
80. Abrahamsohn IA & Coffman RL (1996). Trypanosoma cruzi. IL-10, TNF, IFN-γ, and IL-12 regulate innate and acquired immunity to infection. Experimental Parasitology, 84: 231-244.
81. Gazzinelli RT, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, Kühn R, Müller W, Trinchieri G & Sher A (1996). In the absence of endogenous IL-10 mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompaed by overproduction of IL-12, IFN-γ, and TNF-α. Journal of Immunology, 157: 798-805.
82. Gately MK, Warrier RR, Honasoge S, Carvajal DM, Farherty DA, Connaughton SE, Anderson TD, Sarmiento U, Hubbard BR & Murphy M (1994). Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. International Immunology. 6: 157-167.
83. Silva SJ, Twardzik DR & Reed SG (1991). Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor-β (TGF-β). Journal of Experimental Medicine, 174: 539-545.
84. Barrai A, Barral-Netto M, Yong EC, Brownell CE, Twardzik DR & Reed SG (1993). Transforming growth factor-β as a virulence mechanism for Leishmania braziliensis. Proceedings of the National Academy of Sciences, USA, 90: 3442-3446.
85. Barral-Netto M, Barrai A, Brownell CE, Skeiky YAW, Ellingsworth LR, Twardzik DR & Reed SG (1992). Transforming growth factor-β in leishmanial infection: a parasite escape mechanism. Science, 257: 545-548.
86. Liew FY, Millott S, Li Y, Lelchuk R, Chan WL & Ziltener H (1989). Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis. European Journal of Immunology, 19: 1227-1232.
87. Roberts CW, Ferguson DJ, Jebbari H, Satoskar A, Bluethmann H & Alexander J (1996). Different roles for interleukin-4 during the course of Toxoplasma gondii infection. Infection and Immunity, 64: 897-904.
88. James S (1995). Role of nitric oxide in parasitic infections. Microbiological Reviews, 59: 533-547.
89. Moore KJ & Matlashewski G (1994). Intracellular infection by Leishmania donovaniinhibits macrophage apoptosis. Journal of Immunology, 152: 2930-2937
90. + T cell death by apoptosis in experimental Chagas' disease. Journal of Immunology, 154: 744-752.
91. Martins GA, Cardoso MGA, Aliberti JCS & Silva JS (1995). Modulation of apoptosis cell death by nitric oxide in Trypanosoma cruzi infected mice. Memórias do Instituto Oswaldo Cruz. 90 (Suppl): 171 (Abstract).
92. Candolfi E, Hunter CA & Remington JS (1994). Mitogen and antigen specific proferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates. Infection and Immunity, 62: 1995-2001
93. Hayashi S, Chan CC, Gazzinelli RT & Roberge FG (1996). Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis. Journal of Immunology, 156: 1476-1481.
94. Scharton-Kersten T, Yap G & Sher A (1997). Inducible nitric oxide synthase knockout mice are susceptible to chronic but not acute infection with avirulent strain of Toxoplasma gondii. Journal of Experimental Medicine, 185: 1261-1273.
95. Green SJ, Meltzer MS, Hibbs JB & Nacy CA (1990). Activated macrophages destroy Leishmania major amastigotes by an L-arginine dependent killing mechanism. Journal of Immunology, 144: 278-283.
96. Liew FY, Millott S, Parkinson C, Palmer RMJ & Moncada S (1990). Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. Journal of Immunology, 144: 4794-4797.
97. Wei XQ, Charles IG, Smith A, Ure J, Feng G, Huang F, Xu D, Muller W, Moncada S & Liew FY (1995). Altered immune responses in mice lacking inducible nitric oxide synthase. Nature, 375: 408-411.
98. . Schofield L & Hackett F (1993). Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. Journal of Experimental Medicine, 177: 145-153.
99. Schofield L, Novakovic S, Gerold P, Schwarz RT, McConville MJ & Tachado SD (1996). Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and E-selectin expression in vascular endothelium cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. Journal of Immunology, 156: 1886-1896.
100. Tachado SD, Gerold P, McConville MJ, Baldwin T, Quilici B, Schwarz RT & Schofield L (1996). Glycosytphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelium cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway. Journal of Immunology, 156: 1897-1907.
101. Tachado SD & Schofield L (1994). Glycosylphosphatidylinositol toxin of Trypanosoma brucei regulates IL-1β and TNF-α expression in macrophages by protein tyrosine kinase mediated signal transducon. Biochemical and Biophysical Research Communications, 205: 984-991.
102. Reiner NE, Winnie NG, Wilson CB, McMaster WR & Burchett S (1990). Modulation of in vitro monocyte responses to Leishmania donovani. Journal of Clinical Investigation, 85: 1914-1924.
103. Descoteaux A, Turco SJ, Sacks DL & Matlashewski G (1991). Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophages. Journal of Immunology, 146: 2747-2753.
104. Frankenburg S, Leibovici V, Mansbach N, Turco SJ & Rosen G (1990). Effects of glycolipids of Leishmania parasites on human monocyte activity. Inhibition by lipophosphoglycan. Journal of Immunology, 145: 4284-4289.
105. Hatzigeorgiou DE, Geng J, Zhu B, Zhang Y, Liu K, Rom WN, Fenton MJ, Turco SJ & Ho JL (1996). Lipophosphoglycan from Leishmania suppresses agonist-induced interleukin 1β gene expression in human monocytes via a unique promoter sequence. Proceedings of the National Academy of Sciences, USA, 93: 14708-14713.